Education
About Us
Working with TipRanks
Follow Us
Bio Green Med Solution (BGMS)
NASDAQ:BGMS
BGMS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.08 - $597.60
Previous CloseN/A
VolumeN/A
Average Volume (3M)178.69K
Market Cap
$13.48M
Enterprise Value$3.59M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,238,984
10 Day Avg. Volume133,386
30 Day Avg. Volume178,687
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.27
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BGMS FAQ
What was Bio Green Med Solution’s price range in the past 12 months?
Bio Green Med Solution lowest stock price was $3.08 and its highest was $597.60 in the past 12 months.
What is Bio Green Med Solution’s market cap?
Bio Green Med Solution’s market cap is $13.48M.
When is Bio Green Med Solution’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bio Green Med Solution’s earnings last quarter?
Currently, no data Available
Is Bio Green Med Solution overvalued?
According to Wall Street analysts Bio Green Med Solution’s price is currently Undervalued.
Does Bio Green Med Solution pay dividends?
Bio Green Med Solution does not currently pay dividends.
What is Bio Green Med Solution’s EPS estimate?
Bio Green Med Solution’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio Green Med Solution have?
Bio Green Med Solution has 2,238,984 shares outstanding.
What happened to Bio Green Med Solution’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bio Green Med Solution?
Currently, no hedge funds are holding shares in BGMS
Company Description
Bio Green Med Solution
Cyclacel Pharmaceuticals (CYCC) is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. The company specializes in cell cycle control and DNA damage response technologies, aiming to address unmet medical needs in oncology. Cyclacel's core products involve a portfolio of oral therapies targeting various cancer types, with a focus on solid tumors and hematological malignancies.
Bio Green Med Solution (BGMS) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Karyopharm Therapeutics
―
Avalo Therapeutics
―
Applied Therapeutics
―
Prelude Therapeutics
―
ImageneBio
―